Return on average equity - 5 year average | 8.92 |
Net Income/employee - trailing 12 month | 1,54,505.30 |
Revenue/employee - most recent fiscal year | 46,81,624.00 |
Return on investment - most recent fiscal year | 4.68 |
Return on average assets - most recent fiscal year | 3.31 |
Receivables turnover - most recent fiscal year | 2.98 |
Return on investment - trailing 12 month | 2.76 |
Return on average assets - trailing 12 month | 1.99 |
Inventory turnover - most recent fiscal year | 2.04 |
Inventory turnover - trailing 12 month | 1.67 |
Revenue/employee - trailing 12 month | 48,04,595.00 |
Return on average assets - 5 year average | 5.89 |
Net Income/employee - most recent fiscal year | 2,47,885.10 |
Return on average equity - trailing 12 month | 3.12 |
Receivables turnover - trailing 12 month | 2.76 |
Asset turnover - most recent fiscal year | 0.63 |
Asset turnover - trailing 12 month | 0.62 |
Return on average equity - most recent fiscal year | 5.46 |
Return on investment - 5 year average | 8.45 |
Medicamen Biotech Dividend Medicamen Biotech Bonus Medicamen Biotech News Medicamen Biotech AGM Medicamen Biotech Rights Medicamen Biotech Splits Medicamen Biotech Board Meetings Medicamen Biotech Shareholdings Medicamen Biotech Profit Loss Medicamen Biotech Balance Sheet Medicamen Biotech Cashflow Medicamen Biotech Q1 Results Medicamen Biotech Q2 Results Medicamen Biotech Q3 Results Medicamen Biotech Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks